Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication. - Suppr | 超能文献

Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication.

作者信息

Yilmaz Mehmet Birhan, Akin Yesim, Biyikoglu Senay Funda, Guray Umit, Korkmaz Sule

出版信息

Int J Cardiol. 2004 Jan;93(1):81-2. doi: 10.1016/s0167-5273(03)00130-x.

DOI:10.1016/s0167-5273(03)00130-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication.

Int J Cardiol. 2004 Jan;93(1):81-2. doi: 10.1016/s0167-5273(03)00130-x.

2

Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty.替罗非班诱导的弥漫性肺泡出血：在直接经皮冠状动脉腔内血管成形术后

Tex Heart Inst J. 2012;39(1):99-103.

3

Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.替罗非班或阿昔单抗给药后发生的弥漫性肺泡出血：血小板糖蛋白IIb/IIIa抑制剂的一大难题。

Catheter Cardiovasc Interv. 2000 Feb;49(2):181-4. doi: 10.1002/(sici)1522-726x(200002)49:2<181::aid-ccd14>3.0.co;2-j.

4

Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome.急性冠状动脉综合征治疗中并发的大量肺出血。

Heart. 2004 Mar;90(3):e15. doi: 10.1136/hrt.2003.028589.

5

Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban.使用IIb/IIIa抑制剂替罗非班治疗后，活化重组因子VII（rFVIIa）在出血管理中的应用。

Thromb Haemost. 2002 Feb;87(2):355-6.

6

Alveolar hemorrhage following tirofiban treatment. A misleading diagnosis.替罗非班治疗后出现肺泡出血。一种误诊。

Rev Esp Cardiol. 2010 Dec;63(12):1511-2. doi: 10.1016/s1885-5857(10)70288-7.

7

Alveolar hemorrhage following tirofiban treatment. A misleading diagnosis.替罗非班治疗后发生的肺泡出血。一个具有误导性的诊断。

Rev Esp Cardiol. 2010 Mar;63(3):368-9. doi: 10.1016/s1885-5857(10)70074-8.

8

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.阿昔单抗或替罗非班所致血小板减少症及其与接受冠状动脉支架置入术患者临床结局的关联

Circulation. 2004 May 11;109(18):2203-6. doi: 10.1161/01.CIR.0000127867.41621.85. Epub 2004 Apr 26.

9

Use of platelet glycoprotein IIb/IIIa inhibitors and spontaneous pulmonary hemorrhage.

J Invasive Cardiol. 2003 Apr;15(4):186-8.

10

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.替罗非班抑制血小板糖蛋白IIb/IIIa受体在不稳定型心绞痛和非Q波心肌梗死中的应用

N Engl J Med. 1998 May 21;338(21):1488-97. doi: 10.1056/NEJM199805213382102.

引用本文的文献

1

A fatal complication of tirofiban in an octogenarian: Diffuse alveolar hemorrhage.替罗非班在一位八旬老人身上引发的致命并发症：弥漫性肺泡出血。

J Cardiol Cases. 2010 Mar 21;2(1):e48-e51. doi: 10.1016/j.jccase.2010.02.002. eCollection 2010 Aug.

2

Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review.严重血小板减少症和肺泡出血是替罗非班治疗期间的两种出血倾向类型：病例报告和文献复习。

Int J Hematol. 2012 Sep;96(3):370-5. doi: 10.1007/s12185-012-1133-7. Epub 2012 Jul 6.

3

Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty.替罗非班诱导的弥漫性肺泡出血：在直接经皮冠状动脉腔内血管成形术后

Tex Heart Inst J. 2012;39(1):99-103.